Company / Book Value per Share
United Therapeutics Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$158.287
FY2025
5-year range
$88.95 / $158.287
FY2021-FY2025
Trend
+15.5%
vs FY2024
Sector context
#4 of 209
Health Care
What the data says
Among 209 Health Care companies, United Therapeutics is in the top 2% for book value per share. Book Value per Share has increased for 6 consecutive years, from $63.788 in FY2019 to $158.287 in FY2025.
Based on SEC 10-K filings.
$158.287 in FY2025 with a 5-year CAGR of +15.4%. Top quartile in the Health Care sector.
Improved from $130.014 to $158.287 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- +14.2%
- 5-Year CAGR
- +15.4%
- 10-Year CAGR
- -
Sector benchmark
-16.4% below sector average
Key checks
Key Insights
- United Therapeutics's book value per share has grown for 6 consecutive years.
- 5-year CAGR of +15.4%, indicating consistent growth.
- In FY2025, book value per share increased 15.5% year-over-year.
- Ranks #4 out of 209 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 6.00 (safe zone, above 2.9 threshold)
- Strong profit margin: 40.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $158.287 | +15.5% |
| FY2024 | $136.988 | +5.4% |
| FY2023 | $130.014 | +22.3% |
| FY2022 | $106.339 | +19.5% |
| FY2021 | $88.95 | +15.0% |
| FY2020 | $77.367 | +21.3% |
| FY2019 | $63.788 | -1.1% |
| FY2018 | $64.492 | +74.4% |
| FY2017 | $36.974 | -8.6% |
| FY2016 | $40.456 | +20.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026